These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 27578113)
1. Patterns and predictors of medication adherence to lipid-lowering therapy in children aged 8 to 20 years. Joyce NR; Wellenius GA; Eaton CB; Trivedi AN; Zachariah JP J Clin Lipidol; 2016; 10(4):824-832.e2. PubMed ID: 27578113 [TBL] [Abstract][Full Text] [Related]
2. Adherence to lipid-lowering therapy and risk for cardiovascular disease and death in type 1 diabetes mellitus: a population-based study from the Swedish National Diabetes Register. Hero C; Karlsson SA; Franzén S; Svensson AM; Miftaraj M; Gudbjörnsdottir S; Andersson Sundell K; Eliasson B; Eeg-Olofsson K BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958300 [TBL] [Abstract][Full Text] [Related]
3. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors. Calip GS; Elmore JG; Boudreau DM Breast Cancer Res Treat; 2017 Jan; 161(1):161-172. PubMed ID: 27826756 [TBL] [Abstract][Full Text] [Related]
4. Factors of hyperlipidemia medication adherence in a nationwide health plan. Wiegand P; McCombs JS; Wang JJ Am J Manag Care; 2012 Apr; 18(4):193-9. PubMed ID: 22554007 [TBL] [Abstract][Full Text] [Related]
5. Patterns of Lipid Lowering Therapy among Children Ages 8-20 Years. Joyce N; Wellenius GA; Dore DD; Newburger JW; Zachariah JP J Pediatr; 2015 Jul; 167(1):113-9.e1. PubMed ID: 25953004 [TBL] [Abstract][Full Text] [Related]
6. Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: a retrospective cohort study in South Korea. Han KT; Kim S BMC Cancer; 2022 Feb; 22(1):156. PubMed ID: 35135497 [TBL] [Abstract][Full Text] [Related]
7. Discontinuation and Nonadherence to Medications for Chronic Conditions after Hematopoietic Cell Transplantation: A 6-Year Propensity Score-Matched Cohort Study. Zhou J; Han J; Nutescu EA; Patel PR; Sweiss K; Calip GS Pharmacotherapy; 2019 Jan; 39(1):55-66. PubMed ID: 30485471 [TBL] [Abstract][Full Text] [Related]
8. Lifestyle factors as predictors of nonadherence to statin therapy among patients with and without cardiovascular comorbidities. Halava H; Korhonen MJ; Huupponen R; Setoguchi S; Pentti J; Kivimäki M; Vahtera J CMAJ; 2014 Sep; 186(12):E449-56. PubMed ID: 24958839 [TBL] [Abstract][Full Text] [Related]
9. Gender Disparities in Lipid-Lowering Therapy in Cardiovascular Disease: Insights from a Managed Care Population. Rodriguez F; Olufade TO; Ramey DR; Friedman HS; Navaratnam P; Heithoff K; Foody JM J Womens Health (Larchmt); 2016 Jul; 25(7):697-706. PubMed ID: 26889924 [TBL] [Abstract][Full Text] [Related]
10. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis. Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998 [TBL] [Abstract][Full Text] [Related]
11. Prescriber continuity and medication adherence for complex patients. Hansen RA; Voils CI; Farley JF; Powers BJ; Sanders LL; Sleath B; Maciejewski ML Ann Pharmacother; 2015 Mar; 49(3):293-302. PubMed ID: 25549627 [TBL] [Abstract][Full Text] [Related]
12. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. Corrao G; Conti V; Merlino L; Catapano AL; Mancia G Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788 [TBL] [Abstract][Full Text] [Related]
13. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia. Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815 [TBL] [Abstract][Full Text] [Related]
14. [Use of the EvalObs Girerd X; Hanon O; Vaïsse B Ann Cardiol Angeiol (Paris); 2018 Jun; 67(3):186-190. PubMed ID: 29786508 [TBL] [Abstract][Full Text] [Related]
15. Increase in lipid-lowering treatment rates among TRICARE beneficiaries: a population-based study. Devine J; Linton A; Mistry H; Napier J; Trice S; Bacon T Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):891-9. PubMed ID: 19634117 [TBL] [Abstract][Full Text] [Related]
16. Consistent use of lipid lowering therapy in HIV infection is associated with low mortality. Drechsler H; Ayers C; Cutrell J; Arasaratnam R; Bedimo R BMC Infect Dis; 2021 Feb; 21(1):150. PubMed ID: 33546621 [TBL] [Abstract][Full Text] [Related]
17. Transition probabilities and predictors of adherence in a California Medicaid population using antihypertensive and lipid-lowering medications. Nichol MB; Knight TK; Wu J; Tang SS; Cherry SB; Benner JS; Hussein M Value Health; 2009 Jun; 12(4):544-50. PubMed ID: 19138308 [TBL] [Abstract][Full Text] [Related]
18. Relation of statin nonadherence and treatment intensification. Pittman DG; Fenton C; Chen W; Haffner S; Pendergrass M Am J Cardiol; 2012 Nov; 110(10):1459-63. PubMed ID: 22877424 [TBL] [Abstract][Full Text] [Related]
19. Importance of including early nonadherence in estimations of medication adherence. Raebel MA; Carroll NM; Ellis JL; Schroeder EB; Bayliss EA Ann Pharmacother; 2011 Sep; 45(9):1053-60. PubMed ID: 21852598 [TBL] [Abstract][Full Text] [Related]
20. Non adherence to lipid-lowering therapy and strategies to improve adherence. Mehta A Indian Heart J; 2024 Mar; 76 Suppl 1(Suppl 1):S138-S140. PubMed ID: 38211773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]